Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Facultad de ciencias de la salud y del deporte-Huesca- Universidad de Zaragoza
Retatrutide is an investigational amino acid peptide studied as atriple hormone receptor agonist, simultaneously targeting the GLP-1, GIP, and glucagon receptors to evaluate comprehensive metabolic effects in research
The data shows our customers are experiencing good weight loss on compounded medications, having manageable side-effects through personalized dosing, suggesting the treatment is sustainable and they are making positive strides towards a healthier future
While it is a glucagon-like peptide-1 (GLP-1) agonist, it also activates the glucose-dependent insulinotropic polypeptide (GIP) receptor
Hundt 2018)
US$ 22.46
US$ 25.96
US$ 22.82
US$ 28.15
US$ 27.13
